0001714899-24-000026.txt : 20240105 0001714899-24-000026.hdr.sgml : 20240105 20240105202525 ACCESSION NUMBER: 0001714899-24-000026 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 24518052 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Watts Ryan J. CENTRAL INDEX KEY: 0001724310 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O DENALI THERAPEUTICS INC. STREET 2: 151 OYSTER POINT BLVD., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001724310 XXXXXXXX LIVE 0001714899 Denali Therapeutics Inc. 001-38311 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 6508668548 Watts Ryan J. Director Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

17483 339660.67 138385498 01/05/2024 NASDAQ Common 01/03/2024 Restricted Stock Lapse - See Remarks Denali Therapeutics Inc. N 10151 01/03/2024 Equity Compensation Common 01/04/2024 Restricted Stock Lapse - See Remarks Denali Therapeutics Inc. N 7332 01/04/2024 Equity Compensation Y Shares sold to cover tax obligation from settlement of vested Restricted Stock Units. 01/05/2024 /s/ Tyler Nielsen, by power of attorney